Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Briacell Therapeutics Corp
(NQ:
BCTX
)
0.8423
+0.0952 (+12.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Briacell Therapeutics Corp
< Previous
1
2
3
Next >
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
October 02, 2024
Via
Benzinga
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
September 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge
September 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
September 11, 2024
BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor.
Via
Benzinga
Dow Tumbles 350 Points; US Inflation Rate Slows In August
September 11, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
BriaCell: An Emerging Immuno - Oncology Company
August 14, 2023
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer.
Via
Talk Markets
Exposures
Product Safety
Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer
February 08, 2023
A look at BriaCell's research into a better treatment for prostate cancer.
Via
Talk Markets
BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024
June 14, 2024
BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 28, 2024
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 21, 2024
Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning!
Via
InvestorPlace
BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024
March 19, 2024
BriaCell Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
Get Rich Quick With These 3 Penny Stocks to Buy Now
February 12, 2024
Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
December 20, 2023
BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients...
Via
Benzinga
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock...
Via
Talk Markets
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
January 18, 2023
Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach.
Via
Talk Markets
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Topics
Death
Exposures
Death
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 13, 2022
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX<
Via
Benzinga
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 02, 2022
By Faith Ashmore, Benzinga
Via
News Direct
Exposures
Product Safety
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 01, 2022
The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption.
Via
Benzinga
Why Is BriaCell (BCTX) Stock Moving Today?
April 13, 2022
BriaCell Therapeutics (BCTX) stock is on the move Wednesday morning after getting Fast Track approval from the FDA for Bria-IMT.
Via
InvestorPlace
Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More
April 13, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
Why BriaCell Therapeutics Stock Is Surging Today
April 13, 2022
BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track status...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,...
Via
Benzinga
Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are Ready to Pop
November 08, 2021
Fintel's list of short squeeze stocks to watch for this week is in. Here are the names that investors should be watching.
Via
InvestorPlace
65 Biggest Movers From Yesterday
January 25, 2022
Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...
Via
Benzinga
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Cassava Sciences Joins Following Short Report
November 08, 2021
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:
Via
Benzinga
54 Stocks Moving In Monday's Mid-Day Session
January 24, 2022
Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of...
Via
Benzinga
45 Biggest Movers From Yesterday
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.